Latest kidney cancer Stories
Lenvatinib, investigated in patients with metastatic renal cancer, showed an increase in progression-free survival (PFS) WOODCLIFF LAKE, N.J., June 1, 2015 /PRNewswire/ -- Eisai Inc.
Updated Survival Data and New Report from Prospective Cohort Suggest Benefits of Sequencing Proleukin Before Targeted Therapies CHICAGO, May 28, 2015 /PRNewswire/ -- Prometheus
Data Demonstrates Extension of Survival of Metastatic Melanoma Patients Treated with Proleukin Followed by Immune Checkpoint Blockade of the Programmed Death (PD-1/PD-L1) Pathway CHICAGO,
Analyses of PROCLAIM Patient Registry Data Suggest a Therapy-Enhancing Role with Checkpoint Inhibitors for Patients with mM, and Relevant First-Line Option for Patients with mRCC SAN DIEGO,
Abstracts: 5034, TPS5082, 5063, TPS1104, 3558, 3560, 6015, TPS5080 WHIPPANY, N.J., May 13, 2015 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
New findings presented at American Association for Cancer Research Annual Meeting SANTA ROSA, Calif., April 21, 2015 /PRNewswire/ -- The botanical extract
ADELAIDE, Australia, April 10, 2015 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced that it will present a poster with new data on the DisrupTOR-1
Conference Call Scheduled for Today at 4:30 p.m. ET to Provide Investor Update SAN DIEGO, March 24, 2015 /PRNewswire/ -- Lpath, Inc.
A new approach to treating advanced ovarian cancer may significantly improve patients’ survival compared to standard chemotherapy regimens, according to results published online today as the
NORWALK, Conn., March 5, 2015 /PRNewswire/ -- UBM Medica US announces that OncoTherapy Network,
- The parings of haberdine; also, any kind of fragments.